Creative Medical Technology is witnessing success in the allogeneic cell therapy market and recently made a significant announcement regarding the successful development of AlloStem™, a human perinatal tissue-derived cell line used in an early diabetes clinical trial.

Creative Medical Technology Holdings, Inc. (NASDAQ: $CELZ) is a biotechnology company committed to improving patient lives via a regenerative approach to immunology, endocrinology, urogynecology, and orthopedics.

👉 www.creativemedicaltechnology.com
👉 [ Ссылка ]
👉 [ Ссылка ]
👉 [ Ссылка ]

свернуть